[go: up one dir, main page]

ES492955A0 - Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos - Google Patents

Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos

Info

Publication number
ES492955A0
ES492955A0 ES492955A ES492955A ES492955A0 ES 492955 A0 ES492955 A0 ES 492955A0 ES 492955 A ES492955 A ES 492955A ES 492955 A ES492955 A ES 492955A ES 492955 A0 ES492955 A0 ES 492955A0
Authority
ES
Spain
Prior art keywords
phenylalcanoic
acids
procedure
preparation
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES492955A
Other languages
English (en)
Other versions
ES8106482A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES492955A0 publication Critical patent/ES492955A0/es
Publication of ES8106482A1 publication Critical patent/ES8106482A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • C07D213/6432-Phenoxypyridines; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/14Preparation of carboxylic acid nitriles by reaction of cyanides with halogen-containing compounds with replacement of halogen atoms by cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES492955A 1978-08-08 1980-06-30 Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos Expired ES8106482A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7832609 1978-08-08

Publications (2)

Publication Number Publication Date
ES492955A0 true ES492955A0 (es) 1981-07-01
ES8106482A1 ES8106482A1 (es) 1981-07-01

Family

ID=10498927

Family Applications (3)

Application Number Title Priority Date Filing Date
ES483252A Expired ES483252A1 (es) 1978-08-08 1979-08-08 Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos.
ES492955A Expired ES8106482A1 (es) 1978-08-08 1980-06-30 Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos
ES492954A Expired ES8105690A1 (es) 1978-08-08 1980-06-30 Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES483252A Expired ES483252A1 (es) 1978-08-08 1979-08-08 Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES492954A Expired ES8105690A1 (es) 1978-08-08 1980-06-30 Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos

Country Status (15)

Country Link
US (1) US4472433A (es)
EP (1) EP0008226B1 (es)
JP (1) JPS5551041A (es)
AR (2) AR228019A1 (es)
AT (1) ATE5188T1 (es)
AU (1) AU526877B2 (es)
CA (1) CA1127160A (es)
DE (1) DE2966364D1 (es)
DK (1) DK331679A (es)
ES (3) ES483252A1 (es)
GR (1) GR68102B (es)
HU (1) HU184114B (es)
IE (1) IE48676B1 (es)
PH (1) PH22340A (es)
SU (2) SU1199197A3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4333951A (en) * 1977-11-15 1982-06-08 A. H. Robins Company, Inc. 2-Amino-6-biphenylacetic acids
US4477556A (en) * 1982-08-18 1984-10-16 E. I. Du Pont De Nemours And Company Acidic o-nitroaromatics as photoinhibitors of polymerization in positive working films
JPS61206716A (ja) * 1985-03-12 1986-09-13 Sato Hisao 搬送ロ−ル
US4911754A (en) * 1987-07-16 1990-03-27 American Cyanamid Company Herbicidally active aryloxy saturated 5-membered benzo fused hetero-cyclic compounds
ES2058024B1 (es) * 1992-11-10 1995-05-01 Menarini Lab Nuevo derivado arilpropionico, procedimiento de fabricacion del mismo y su utilizacion como analgesico.
JPH08511011A (ja) * 1993-06-07 1996-11-19 ゼネカ・リミテッド アニリン誘導体
CA2420576C (en) 2000-08-29 2005-06-14 Nobex Corporation Immunoregulatory compounds, derivatives thereof and their use
JP2004529110A (ja) * 2001-03-06 2004-09-24 アストラゼネカ アクチボラグ 脈管損傷活性を有するインドール誘導体
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
PL1773767T3 (pl) 2004-07-07 2016-07-29 Biocon Ltd Synteza azowo związanych związków immunoregulacyjnych
CN109071423A (zh) * 2016-02-09 2018-12-21 益方生物科技(上海)有限公司 吲哚胺-2,3-双加氧酶(ido)抑制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1072998B (de) * 1957-08-21 1960-01-14 Farbwerke Hoechst Aktiengesellschaft vormals Meister Lucius &. Brüning, Frankfurt/M Verfahren zur Herstellung von substituierten Diphenyläthern
FR1657M (fr) * 1961-01-14 1963-02-15 Merck Ag E 5-aleoxy-oxindoles
FR1516142A (fr) * 1967-01-24 1968-03-08 Rhone Poulenc Sa Nouveau procédé de préparation de dérivés de la phénothiazine
US3981905A (en) * 1970-03-16 1976-09-21 Boots Pure Drug Company Limited 2-(Substituted phenyl) propionic acids
JPS512358Y2 (es) * 1971-05-08 1976-01-23
BE795159A (fr) * 1972-02-08 1973-08-08 Thomae Gmbh Dr K Nouveaux acides butendiques, sels et derives de ces acides et procedes pour les preparer
CH569013A5 (es) * 1972-07-21 1975-11-14 Hoffmann La Roche
US4006161A (en) * 1973-12-26 1977-02-01 Eli Lilly And Company Thio-substituted 2-oxo-indolines
JPS511442A (ja) * 1974-06-19 1976-01-08 Fujisawa Pharmaceutical Co Fuenokishifuenirusakusanruino seizoho
JPS5487136A (en) * 1977-12-23 1979-07-11 Fujitsu Ltd Coupler between channels

Also Published As

Publication number Publication date
US4472433A (en) 1984-09-18
SU1199197A3 (ru) 1985-12-15
AR228019A1 (es) 1983-01-14
HU184114B (en) 1984-07-30
IE791490L (en) 1980-02-08
AU526877B2 (en) 1983-02-03
ES483252A1 (es) 1980-09-01
IE48676B1 (en) 1985-04-17
ES492954A0 (es) 1981-06-16
EP0008226A3 (en) 1980-03-05
CA1127160A (en) 1982-07-06
AU4946179A (en) 1981-02-05
AR226446A1 (es) 1982-07-15
EP0008226B1 (en) 1983-11-02
ATE5188T1 (de) 1983-11-15
SU1053743A3 (ru) 1983-11-07
JPS5551041A (en) 1980-04-14
EP0008226A2 (en) 1980-02-20
JPS6256861B2 (es) 1987-11-27
ES8105690A1 (es) 1981-06-16
GR68102B (es) 1981-10-30
PH22340A (en) 1988-08-12
ES8106482A1 (es) 1981-07-01
DK331679A (da) 1980-02-09
DE2966364D1 (en) 1983-12-08

Similar Documents

Publication Publication Date Title
ES494300A0 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos
ES484097A0 (es) Un procedimiento para la preparacion de nuevos derivados de-4-anilinoquinazolinas
ES487379A0 (es) Un procedimiento para la preparacion de nuevas benzamidas sustituidas
ES490214A0 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina
ES488676A0 (es) Un procedimiento para la preparacion de nuevos derivados he-terociclicos
ES487358A0 (es) Un procedimiento para la preparacion de compuestos de cefem y cefam
ES485620A0 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
AR221734A1 (es) Un procedimiento para la preparacion de derivados de n-alquilimidazol
ES490212A0 (es) Un procedimiento para la preparacion de fenetanolaminas
ES492955A0 (es) Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos
ES493195A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES486022A0 (es) Un procedimiento para la preparacion de antibioticos de ce- falosporina
ES484890A0 (es) Un procedimiento para la preparacion de derivados de ciclo- hexadieno
ES489048A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES484677A0 (es) Procedimiento para la preparacion de un conglomerante hi- draulico
ES486696A0 (es) Un procedimiento para la preparacion de nuevas 2(1h)-quina- zolinonas
ES494168A0 (es) Un procedimiento para la preparacion de acidos alfa-aril- propionicos
ES493200A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES489648A0 (es) Un procedimiento para la preparacion de un derivado de cefa-losporina
ES490617A0 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona
ES486884A0 (es) Un procedimiento para la preparacion de naftalen-2-sulfonatode ester ftalidilico de ampicilina
MX5587E (es) Un procedimiento para la preparacion de 2-cloro-4-etilamino-6-isopropilamino-s-triazina
ES486666A0 (es) Un procedimiento para la preparacion de carbetoxi-carbonila-mino-pirimidinas
ES490616A0 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona
ES490521A0 (es) Un metodo para la preparacion de pivaloximetilester de aci- dos 6-beta-amidinopenicilanicos